![]() |
||||
|
||||
|
|
||||
Re: Calculation of Risk for DownFrom: Ph Coquel (philippe.coquel@wanadoo.fr)Fri Feb 23 05:36:51 2001
Yours arguments are correct It is necessary to apply the risk of hyperechogenic bowel the triple screen risk(1:7600) : It is an application of Bayes's theorem In theory, you must apply LLR to odds and not to risk, but in fact and in practice in our range of prevalence, it is about the same thing An important point is the confidence limit For example, if you use data from De Vore in UOG , for non cardio vascular ultrasound markers with a sensitivity of 60% and a false positive rate of 5.9%, the estimed likelihood ratio is 7.24 but is situated between 3.71 and 14.84 with an error of 5% (95% CL). The upper level is about twice the estimated LR LLR: 5.5 risk =1/1382 LLR:7.24 risk =1/1050 LLR: 14.84 risk= 1/512 (upper risk with De Vore data) It is necessary to calculate the risk with the upper LLR , particularly in border line examination For this reason, it is important to know the confidence limits of the triple screening In your case, the problem is the absence of examination of the nuchal translucency during the first trimester with a borderline nuchal fold during the second trimester, two major signs in aneuploidy 35 year old, without examination during the first trimester, a borderline nuchal fold , hyperechoic bowel: I think that an amniocentesis is indicated
-- Ph Coquel,MD
|
|
Return to
|
Mail a New Message to the Forum: ultrasound@obgyn.net Forum Administrator: terry.dubose@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Thu Oct 2 05:18:03 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.